LENZ Therapeutics, Inc. (LENZ) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.22
Day's range
$12.38

LENZ Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 4.18 M $38.24 M   0.00% 13.45%
ALPHA WAVE GLOBAL, LP 05/14/2026 3.61 M $33.05 M   0.00% 11.63%
FMR LLC 05/15/2026 3.60 M $32.92 M   -2.83% 11.58%
VERSANT VENTURE MANAGEMENT, LLC 05/05/2026 2.66 M $24.31 M   0.00% 8.55%
BLACKROCK, INC. 05/13/2026 1.98 M $18.09 M   16.83% 6.36%
SQUAREPOINT OPS LLC 05/15/2026 1.51 M $13.78 M   206.26% 4.85%
ABRDN PLC 04/29/2026 1.16 M $10.58 M   136.23% 3.72%
FRANKLIN RESOURCES INC 05/13/2026 1.10 M $10.07 M   0.35% 3.54%
05/15/2026 1.04 M $9.53 M   100.00% 3.35%
72 INVESTMENT HOLDINGS, LLC 05/15/2026 1.02 M $9.31 M   0.00% 3.28%
MILLENNIUM MANAGEMENT LLC 05/15/2026 869.26 K $7.95 M   61.17% 2.80%
C WORLDWIDE GROUP HOLDING A/S 05/06/2026 700.00 K $6.41 M   40.00% 2.25%
MORGAN STANLEY 05/15/2026 648.85 K $5.94 M   178.02% 2.09%
BANK OF AMERICA CORP /DE/ 05/18/2026 547.53 K $5.01 M   377.41% 1.76%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 524.57 K $4.80 M   13.77% 1.69%
BLUE OWL CAPITAL HOLDINGS LP 05/14/2026 506.72 K $4.64 M   237.81% 1.63%
TWO SIGMA INVESTMENTS, LP 05/15/2026 501.00 K $4.58 M   70.73% 1.61%
PRIMECAP MANAGEMENT CO/CA/ 05/11/2026 472.20 K $4.32 M   26.87% 1.52%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 463.50 K $4.24 M   0.00% 1.49%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 451.11 K $4.13 M   -47.86% 1.45%
STATE STREET CORP 05/15/2026 402.23 K $3.68 M   -21.25% 1.29%
SILVERCREST ASSET MANAGEMENT GROUP LLC 05/15/2026 283.21 K $2.59 M   62.12% 0.91%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 257.46 K $2.36 M   0.00% 0.83%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 05/15/2026 241.30 K $2.21 M   0.00% 0.78%
XTX TOPCO LTD 05/15/2026 221.04 K $2.02 M   157.67% 0.71%
TREXQUANT INVESTMENT LP 05/15/2026 214.41 K $1.96 M   23.80% 0.69%
NORTHERN TRUST CORP 05/14/2026 185.62 K $1.70 M   14.65% 0.60%
GOLDMAN SACHS GROUP INC 05/15/2026 183.76 K $1.68 M   -28.76% 0.59%
MARSHALL WACE, LLP 05/15/2026 160.26 K $1.47 M   354.62% 0.52%
Y-INTERCEPT (HONG KONG) LTD 04/27/2026 158.72 K $1.45 M   290.78% 0.51%
UBS GROUP AG 05/05/2026 156.99 K $1.44 M   -90.01% 0.51%
05/08/2026 153.00 K $1.40 M   100.00% 0.49%
BARCLAYS PLC 05/15/2026 151.39 K $1.39 M   109.01% 0.49%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 149.99 K $1.37 M   100.00% 0.48%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 149.54 K $1.37 M   -11.58% 0.48%
HRT FINANCIAL LP 05/14/2026 145.51 K $1.33 M   -15.05% 0.47%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 140.31 K $1.28 M   100.00% 0.45%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 134.20 K $1.23 M   9.28% 0.43%
SCOGGIN MANAGEMENT LP 05/15/2026 125.00 K $1.14 M   0.00% 0.40%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 117.01 K $1.07 M   -56.81% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 110.30 K $1.01 M   62.88% 0.36%
JUMP FINANCIAL, LLC 05/14/2026 100.20 K $916.83 K   145.28% 0.32%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 100.00 K $915.00 K   100.00% 0.32%
WOODLINE PARTNERS LP 05/15/2026 100.00 K $915.00 K   0.00% 0.32%
ROYAL BANK OF CANADA 05/15/2026 95.24 K $870.00 K   120.59% 0.31%
KBC GROUP NV 05/07/2026 90.43 K $827.00 K   100.00% 0.29%
CITADEL ADVISORS LLC 05/15/2026 78.40 K $717.36 K   -4.51% 0.25%
CITADEL ADVISORS LLC 05/15/2026 75.30 K $689.00 K   278.39% 0.24%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/14/2026 73.34 K $671.06 K   52.57% 0.24%
VIVALDI CAPITAL MANAGEMENT LP 05/14/2026 64.05 K $586.08 K   0.00% 0.21%

LENZ Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 194 institutional investors and hedge funds held shares of LENZ Therapeutics Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 4.18 M

Alpha Wave Global, LP: 3.61 M

FMR LLC: 3.6 M

Versant Venture Management, LLC: 2.66 M

BlackRock, Inc.: 1.98 M

Squarepoint Ops LLC: 1.51 M

106.66% of LENZ Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 34.35 M shares in the last 24 months. This purchase volume represents approximately $422.45 M in transactions.